Study for rare gynecologic cancers
Part of Cancer, Women’s health & pregnancy clinical trials.
This study is looking at people with rare cancers affecting the female reproductive system. It may help researchers learn more about how these cancers behave and how best to follow patients over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a rare cancer involving the gynecologic area
- You are able and willing to sign informed consent (permission to join)
- You can attend follow-up visits and provide updates as the study requests
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows young adults (ages 15-39) with gynecologic cancers to learn about their outcomes and improve care. By joining, you help researchers understand what treatments work best for people your age.
This study looks at tumor tissue and blood samples to find biological “markers” in people with gynecologic cancers. It may help researchers understand disease better and could guide future, more personalized treatments.
This study builds a clinical and biological database for people newly diagnosed with certain cancers. It may help doctors better understand cancer patterns and improve future care, and it involves agreeing to extra blood samples.
This study tests a program to help gynecologic cancer patients who are frail improve their physical function and quality of life during treatment. It aims to see if extra support can help you stay stronger and recover better.
This study looks at the emotional and practical support needs of people with gynecologic cancers and their caregivers. It aims to improve support services by understanding what help people need during chemotherapy treatment.
This study looks at rare or complex tumors in the chest, abdomen, or soft tissues. It aims to learn more about these uncommon cancers and how to best treat them.
Hear when a new Gynecologic Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.